ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NBIX Neurocrine Biosciences Inc

130.86
0.00 (0.00%)
Jun 19 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Neurocrine Biosciences Inc NBIX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 130.86 19:00:00
Open Price Low Price High Price Close Price Previous Close
130.86
more quote information »

Recent News

Date Time Source Heading
6/04/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/03/202407:01PRNUSNeurocrine Biosciences Presented CAHtalyst™ Phase 3..
6/03/202406:35PRNUSNeurocrine Biosciences Announces Publication of Primary..
6/03/202406:30PRNUSNeurocrine Biosciences Announces Publication of Primary..
5/30/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/29/202415:53EDGAR2Form 144 - Report of proposed sale of securities
5/29/202415:01PRNUSNeurocrine Biosciences to Participate at Investor..
5/28/202415:14PRNUSNeurocrine Biosciences Announces CEO Succession Plan
5/28/202407:30PRNUSNeurocrine Biosciences to Present New Phase 3 CAHtalyst™..
5/23/202417:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202417:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202417:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202417:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/23/202415:01EDGAR2Form 8-K - Current report
5/21/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/21/202415:05PRNUSNeurocrine Biosciences Announces Publication of Phase 3..
5/17/202415:32EDGAR2Form 144 - Report of proposed sale of securities
5/17/202415:31EDGAR2Form 144 - Report of proposed sale of securities
5/17/202415:31EDGAR2Form 144 - Report of proposed sale of securities
5/16/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/16/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/14/202415:23EDGAR2Form 144 - Report of proposed sale of securities
5/14/202415:23EDGAR2Form 144 - Report of proposed sale of securities
5/14/202407:30PRNUSNeurocrine Biosciences Presented Baseline Data from the..
5/09/202408:45PRNUSNeurocrine Biosciences Presents CAHtalyst™ Adult Study..
5/09/202407:30PRNUSNeurocrine Biosciences Announces Initiation of Phase 1..
5/08/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/08/202407:30PRNUSNeurocrine Biosciences Announces Initiation of Phase 1..
5/07/202415:15PRNUSNeurocrine Biosciences to Present at the BofA Securities..
5/07/202407:30PRNUSNeurocrine Biosciences to Present Phase 3 Baseline..
5/06/202407:30PRNUSNeurocrine Biosciences Supports Tardive Dyskinesia Awareness..
5/03/202412:15PRNUSNeurocrine Biosciences Presented CAHtalyst™ Pediatric Study..
5/01/202406:00PRNUSNeurocrine Biosciences Reports First Quarter 2024 Financial..
4/30/202416:12PRNUSNeurocrine Biosciences Announces U.S. FDA Approval of..
4/24/202407:30PRNUSNeurocrine Biosciences Launches WHAT THE C@H?! Educational..
4/23/202406:00PRNUSNeurocrine Biosciences Reports Positive Phase 2 Data for..
4/16/202415:01GLOBESentia Medical Sciences and Neurocrine Biosciences Extend..
4/10/202415:01PRNUSNeurocrine Biosciences Announces Conference Call and Webcast..
4/03/202407:30PRNUSNeurocrine Biosciences Announces First-Patient Dosed in..